An interventional study of Nifedipine and Magnesium sulfate in Preterm Labor Without Delivery and Pregnancy Preterm, sponsored by Konya Meram State Hospital. Status unknown at 1 site in Turkey. Open to female participants aged 18 Years to 38 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-15.
Sponsored by Konya Meram State Hospital · Not applicable, Interventional, and Treatment
Comparison of the effects of Nifedipine and MgSO4 therapies on maternal and fetal blood flow.
In this study, the investigators aim to compare the effect of Nifedipine and MgSO4 therapies on Doppler parameters of the uterine, umbilical, middle cerebral arteries, and ductus venous in the first 48 hours of therapy in pregnancies with preterm labor threat and also compare perinatal outcomes after delivery between the groups.
2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.
This study's planned enrollment of 30 is below the median of 84 across 1,689 interventional studies indexed under Premature Birth.
Browse Premature Birth studies →Konya Meram State Hospital is the lead sponsor of 45 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
A total of 30 pregnancies with preterm labor threats will be treated with Magnesium sulfate.
Drug: Magnesium sulfate
A total of 30 pregnancies with preterm labor threats will be treated with Nifedipine.
Drug: Nifedipine
A total of 30 pregnancies without preterm labor threat will be included.
A total of 30 pregnancies with preterm labor threats will be treated with Nifedipine.
A total of 30 pregnancies with preterm labor threats will be treated with Magnesium sulfate.
Doppler parameters
Pulsality index of middle cerebral artery.
Time frame: Gestational age at delivery (weeks)
Perinatal outcomes
NICU admission
Time frame: Gestational age at delivery (weeks)
This study is status unknown, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Konya Meram State Hospital